Explore
Validate
LearnMA1-37783
antibody from Invitrogen Antibodies
Targeting: SLC2A1
CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR
Immunocytochemistry
Immunohistochemistry
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-37783 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-GLUT1 Monoclonal Antibody (SPM498)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- Heat-mediated antigen retrieval is recommended prior to staining, using a 10mM citrate buffer, pH 6.0, for 10 minutes followed by cooling at room temperature for 20 min. Following antigen retrieval, incubate samples with primary antibody for 30 min at room temperature. A suggested positive control is esophageal or breast carcinoma.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- SPM498
- Vial size
- 1 mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer.
αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.
IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.
Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage.
Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations.
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Transforming growth factor-β1 may be a key mediator of the fibrogenic properties of neural cells in leprosy.
Down-regulation of MutS homolog 3 by hypoxia in human colorectal cancer.
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Kong G, Hofman MS, Murray WK, Wilson S, Wood P, Downie P, Super L, Hogg A, Eu P, Hicks RJ
Journal of pediatric hematology/oncology 2016 Mar;38(2):87-96
Journal of pediatric hematology/oncology 2016 Mar;38(2):87-96
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
Sohn CH, Park SP, Choi SH, Park SH, Kim S, Xu L, Kim SH, Hur JA, Choi J, Choi TH
Nanomedicine : nanotechnology, biology, and medicine 2015 Jan;11(1):127-35
Nanomedicine : nanotechnology, biology, and medicine 2015 Jan;11(1):127-35
HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ, Park JJ, Ko GH, Seo JH, Jeong BK, Kang KM, Woo SH, Kim JP, Hwa JS, Carey TE
Head & neck 2015 Apr;37(4):505-10
Head & neck 2015 Apr;37(4):505-10
High-risk human papillomavirus load and biomarkers in cervical intraepithelial neoplasia and cancer.
Chang MS, Oh S, Jung EJ, Park JH, Jeon HW, Lee TS, Kim JH, Choi E, Byeon SJ, Park IA
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2014 May;122(5):427-36
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2014 May;122(5):427-36
αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
Malin D, Strekalova E, Petrovic V, Deal AM, Al Ahmad A, Adamo B, Miller CR, Ugolkov A, Livasy C, Fritchie K, Hamilton E, Blackwell K, Geradts J, Ewend M, Carey L, Shusta EV, Anders CK, Cryns VL
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jan 1;20(1):56-67
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jan 1;20(1):56-67
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma.
Kashyap R, Lau E, George A, Seymour JF, Lade S, Hicks RJ, Hofman MS
European journal of nuclear medicine and molecular imaging 2013 Sep;40(9):1330-6
European journal of nuclear medicine and molecular imaging 2013 Sep;40(9):1330-6
IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.
Lee AF, Gown AM, Churg A
The American journal of surgical pathology 2013 Mar;37(3):421-6
The American journal of surgical pathology 2013 Mar;37(3):421-6
Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage.
Renkonen S, Heikkilä P, Haglund C, Mäkitie AA, Hagström J
Head & neck 2013 Jul;35(7):1036-42
Head & neck 2013 Jul;35(7):1036-42
Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations.
Partanen TA, Vuola P, Jauhiainen S, Lohi J, Salminen P, Pitkäranta A, Häkkinen SK, Honkonen K, Alitalo K, Ylä-Herttuala S
Angiogenesis 2013 Jan;16(1):137-46
Angiogenesis 2013 Jan;16(1):137-46
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Kim BW, Cho H, Chung JY, Conway C, Ylaya K, Kim JH, Hewitt SM
Journal of translational medicine 2013 Aug 8;11:185
Journal of translational medicine 2013 Aug 8;11:185
Transforming growth factor-β1 may be a key mediator of the fibrogenic properties of neural cells in leprosy.
Petito RB, Amadeu TP, Pascarelli BM, Jardim MR, Vital RT, Antunes SL, Sarno EN
Journal of neuropathology and experimental neurology 2013 Apr;72(4):351-66
Journal of neuropathology and experimental neurology 2013 Apr;72(4):351-66
Down-regulation of MutS homolog 3 by hypoxia in human colorectal cancer.
Li J, Koike J, Kugoh H, Arita M, Ohhira T, Kikuchi Y, Funahashi K, Takamatsu K, Boland CR, Koi M, Hemmi H
Biochimica et biophysica acta 2012 Apr;1823(4):889-99
Biochimica et biophysica acta 2012 Apr;1823(4):889-99
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Kim JW, Kwon GY, Roh JL, Choi SH, Nam SY, Kim SY, Cho KJ
Journal of Korean medical science 2011 Oct;26(10):1277-85
Journal of Korean medical science 2011 Oct;26(10):1277-85
No comments: Submit comment
Enhanced validation
- Submitted by
- Invitrogen Antibodies (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Knockdown of GLUT1 was achieved by transfecting Hep G2 cells with GLUT1 specific siRNA (Silencer®
